Fred Lampropoulos, CEO, Merit Medical
Peter Cataldo, Managing Director, Wells Fargo Securities
I started this business in 1987. I had some good friends who are cardiologists, and I just went and hung out in the hospitals all day long. And wrote a business plan.
The product that put us on the map was our inflation systems. These are syringes that are used to blow up angioplasty balloons. Today we’re the number one company in the world for inflation systems.
You can have several great ideas, but at the end of the day, they have a lifetime. And when those are over, if you don’t have several more, then you’re in trouble.
1,500 global patents held by Merit Medical
Wells Fargo has a broad-based relationship with Merit Medical – everything from providing corporate banking products to advice around acquisitions.
What’s unusual about Fred is the passion he has for this business, for his people, for innovation.
We improve the health of 15,000 people a day, every day. Without Wells Fargo — without their understanding of our business, their advice, their innovation – we couldn’t do that.
Last summer, we raised 217 million dollars in an equity offering. Within five months of completing that equity offering, Merit completed two acquisitions, including the largest acquisition the company’s ever made to date.
They did it so well that I’ve already committed the next deal I do will be Wells Fargo.
189% increase in Merit Medical’s stock price since 2016
Business conditions ebb and flow. There are good times, there are bad times. If you have the right partner, they’re kind of always good times.